Hector Llanas Marco is a visionary leader and entrepreneur with over eleven years of international experience across the Pharmaceutical, MedTech, and R&D industries. Before founding Avant Pharma Consulting, he served as Chief Operating Officer (COO), where he built a solid reputation for driving operational excellence and leading large-scale strategic transformations.

His professional background includes end-to-end management of global product launches, large-scale demand planning, portfolio life cycle management, and the successful execution of high-impact strategic initiatives. Hector’s expertise in fostering cross-functional collaboration and delivering organizational success has been recognized by leading global corporations.

He has been awarded by Johnson & Johnson for the successful launch of new products and by Novartis for leading the global transition and spin-off of Alcon, an operation valued at over USD 3 billion in sales.

An adaptable and naturally curious leader, Hector is known for his unwavering commitment to quality, integrity, and a positive work culture. At Avant Pharma Consulting, his vision is to empower organizations to achieve operational excellence and strategic innovation — shaping the future of the healthcare industry.